MeSH tree: C04.557.470.200.025.390
Eligibility requirements for clinical trials help protect patients whose comorbidities may put them at an additional risk of severe harm from the treatment being tested. Further, they help ensure that analyses are performed ...
Jun 27, 2024
0
59
Researchers from the University of Michigan Health Rogel Cancer Center have discovered a biomarker that could help identify which renal cancer patients have a higher risk of recurrence.
Jun 25, 2024
0
45
Losing weight can protect you against cancers related to obesity, a new study finds. The findings are published in the journal Diabetes.
Jun 25, 2024
0
47
Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types. Diagnostic criteria have advanced from purely morphological features to include histochemistry, ...
Jun 18, 2024
0
44
Close to half of America's tap water contains PFAS, or perfluoroalkyl and polyfluoroalkyl substances. These "forever chemicals" are in thousands of products, from clothing and cosmetics to cleaning products, and are linked ...
Jun 12, 2024
0
82
For nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Now a study by researchers at UT Southwestern Medical Center's Kidney Cancer Program sheds light. Published ...
Jun 12, 2024
0
59
Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.
Jun 4, 2024
0
59
Immunotherapy increases survival rates in kidney cancer, but does not work for everyone. A Leuven research team has developed a new method to predict which patients will benefit from it. The team of Francesca Finotello (Computational ...
May 24, 2024
0
68
A novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients according to new research published in the May issue of The Journal of Nuclear Medicine.
May 7, 2024
0
50
A new study led by University of Michigan Health Rogel Cancer Center researchers identifies novel biomarkers in renal cell carcinomas. The researchers' integrative analysis of comprehensive proteogenomic datasets from both ...
May 6, 2024
0
67
